Monounsaturated fatty acids, olive oil and health status: a systematic review and meta-analysis of cohort studies.

Schwingshackl L, Hoffmann G. · 2014

Read Monounsaturated fatty acids, olive oil and health status: a systematic review and meta-analysis of cohort studies. by Schwingshackl L, Hoffmann G. (2014) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc4198773.txt.

Introduction

Lukas Schwingshackl and Georg Hoffmann pooled cohort studies on monounsaturated fat and olive oil in Lipids in Health and Disease in 2014. Olive oil is a hallmark of the Mediterranean diet, and its main fat type, monounsaturated fat, is often credited with heart benefits. The pair asked whether the fat itself, from any source, earns that credit.

They combined 32 cohort studies covering 841,211 people. Comparing the highest and lowest thirds of intake for the fat and oil measures together gave lower risks of death overall, heart death, heart events, and stroke. Split apart, though, only olive oil kept clear links with lower risk; monounsaturated fat mixed from animal and plant sources showed none. The results point to olive oil itself, or its other compounds, rather than the fat class alone.

Catalog record

CREATORSchwingshackl L, Hoffmann G.
YEAR2014
COLLECTIONPAPERS
FORMATTXT
FILE SIZE43 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC4198773

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Monounsaturated fatty acids, olive oil and health status: a systematic review and meta-analysis of cohort studies By Lukas Schwingshackl, Georg Hoffmann Published in: Lipids in Health and Disease DOI: 10.1186/1476-511X-13-154 ABSTRACT Abstract Background The aim of the present meta-analysis of cohort studies was to focus on monounsaturated fat (MUFA) and cardiovascular disease, cardiovascular mortality as well as all-cause mortality, and to distinguish between the different dietary sources of MUFA. Methods Literature search was performed using the electronic databases PUBMED, and EMBASE until June 2nd, 2014. Study specific risk ratios and hazard ratios were pooled using a inverse variance random effect model. Results Thirty-two cohort studies (42 reports) including 841,211 subjects met the objectives and were included. The comparison of the top versus bottom third of the distribution of a combination of MUFA (of both plant and animal origin), olive oil, oleic acid, and MUFA:SFA ratio in each study resulted in a significant risk reduction for: all-cause mortality (RR: 0.89, 95% CI 0.83, 0.96, p = 0.001; I2 = 64%), cardiovascular mortality (RR: 0.88, 95% CI 0.80, 0.96, p = 0.004; I2 = 50%), cardiovascular events (RR: 0.91, 95% CI 0.86, 0.96, p = 0.001; I2 = 58%), and stroke (RR: 0.83, 95% CI 0.71, 0.97, p = 0.02; I2 = 70%). Following subgroup analyses, significant associations could only be found between higher intakes of olive oil and reduced risk of all-cause mortality, cardiovascular events, and stroke, respectively. The MUFA subgroup analyses did not reveal any significant risk reduction. Conclusion The results indicate an overall risk reduction of all-cause mortality (11%), cardiovascular mortality (12%), cardiovascular events (9%), and stroke (17%) when comparing the top versus bottom third of MUFA, olive oil, oleic acid, and MUFA:SFA ratio. MUFA of mixed animal and vegetable sources per se did not yield any significant effects on these outcome parameters. However, only olive oil seems to be associated with reduced risk. Further research is necessary to evaluate specific sources of MUFA (i.e. plant vs. animal) and cardiovascular risk. Electronic supplementary material The online version of this article (doi:10.1186/1476-511X-13-154) contains supplementary material, which is available to authorized users. Keywords: Monounsaturated fatty acids, Olive oil, Cohort studies, Meta-analysis, Cardiovascular disease BACKGROUND The most common monounsaturated fatty acids (MUFA) in daily nutrition is oleic acid, followed by palmitoleic acid, and vaccenic acid. Moreover, oleic acid represents the topmost MUFA provided in the diet (~90% of all MUFA). No dietary recommendations for MUFA are given by the National Institute of Medicine, the United States Department of Agriculture, the European Food and Safety Authority and the American Diabetes Association. In contrast, the Academy of Nutrition and Dietetics as well as the Canadian Dietetic Association both promote <20% MUFA of daily total energy consumption, while the American Heart Association sets a limit of 20% MUFA in their respective guidelines [1–3]. One reason for specific MUFA recommendations might be their potential benefit in the primary and secondary prevention of cardiovascular diseases. However, previous meta-analyses of cohort studies reported inconsistent results of MUFA on coronary heart disease (CHD). Jakobsen et al. [4] observed that replacement of SFA by MUFA marginally increased the risk of coronary events, whereas no significant effects on coronary death could be observed. These results are in strong discrepancy with another meta-analysis of cohort studies, were Mente et al. [5] reported a significant correlation between MUFA intake and a decrease in the relative risk for CHD. Skeaff and Miller [6] did not observe any effects of MUFA-rich diets on relative risks of CHD events and CHD death. Likewise, the most recent meta-analysis by Chowdhury et al. including nine cohort studies found no significant associations between MUFA intake, circulating MUFA and risk of CHD [7]. One explanation for these inconclusive data might be that different sources of MUFA were not taken into account. Adopting a western diet means that MUFA is predominantly supplied by foods of animal origin, while in south European countries, extra virgin olive oil is the most dominant source of this type of fatty acid [8]. Results of the recently published PREDIMED trial demonstrated major cardiovascular benefits of olive oil and nuts when compared to a low-fat diet [9]. As a major outcome parameter, the risk of stroke was reduced, an event which has not been included in the meta-analyses mentioned above. In addition, a recent cohort study observed a significant association between dietary olive oil, higher plasma oleic acid and reduced risk of stroke [10]. Extra virgin olive oil is regarded to be the genuine driver of the Mediterranean diet and was found to be associated with a 26% reduced risk of all-cause mortality in the Spanish branch of the EPIC study [11]. The aim of the present meta-analysis of cohort studies was to focus on MUFA and CVD (combining CHD and stroke), cardiovascular mortality, and all-cause mortality, and to distinguish between the different dietary sources of MUFA (e.g. olive oil). MATERIALS AND METHODS Literature search Queries of literature were performed using the electronic databases PUBMED, and EMBASE (until 2nd June 2014, respectively) with no restrictions to language, and calendar date using the following search terms: (“dietary fat” OR “fatty acids” OR “monounsaturated fat” OR “mufa” OR “olive oil” OR “oleic acid” OR “mediterranean diet”) AND (“cardiovascular disease” OR “myocardial infarction” OR “coronary heart disease” OR “stroke” OR “mortality”) AND (“incidence” OR “cohort” OR “follow-up” OR “prospective” OR “risk ratio” OR “hazard ratio” OR “rate ratio”). Moreover, the reference lists from retrieved articles, systematic reviews, and meta-analyses were checked to search for further relevant studies. This systematic review was planned, conducted, and reported in adherence to standards of quality for reporting meta-analyses [12]. Literature search was conducted independently by both authors, with disagreements resolved by consensus. Eligibility criteria Studies were included in the meta-analysis if they met all of the following criteria: (i) cohort study design; (ii) data related to dietary consumption of MUFA, MUFA:SFA ratio, olive oil, and oleic acid; (iii) the primary outcomes were: all-cause mortality, CVD mortality, combined CVD events (cardiovascular mortality, cardiovascular morbidity (non-fatal myocardial infarction, angina, stroke, heart failure, peripheral vascular events)); the secondary outcomes were: coronary heart disease, and stroke; (iv) adjusted relative risks (RRs), and hazard ratios (HRs) with corresponding 95% confidence intervals (95% CIs) or the data necessary to calculate these; (v) when a study appeared to have been published in duplicate, the version containing the most comprehensive information was selected. Data extraction and quality assessment The following data were extracted from each study: the first author’s last name, year of publication, study origin, outcome parameter, sample size, study length, age at entry, sex, specification of MUFA, adjustment factors, quality score, and risk estimates (HR, RR; highest vs. lowest category) with their corresponding 95% CIs. If separate risk estimates for males and females or separate risk estimates for ages were available in one study, the data were pooled and treated as one study. When a study provided several risk estimates, the maximally adjusted model was chosen. To assess the study quality, a 9-point scoring system according to the Newcastle-Ottawa Scale (NOS) was used. Hence, the full score was 9, and a high-quality study in the present analysis was defined by a threshold of ≥ 7 points [13]. Data extraction and

Read the complete text